CN102784318A - 一种治疗尿频尿急型失眠的中药制备方法 - Google Patents
一种治疗尿频尿急型失眠的中药制备方法 Download PDFInfo
- Publication number
- CN102784318A CN102784318A CN2012102709155A CN201210270915A CN102784318A CN 102784318 A CN102784318 A CN 102784318A CN 2012102709155 A CN2012102709155 A CN 2012102709155A CN 201210270915 A CN201210270915 A CN 201210270915A CN 102784318 A CN102784318 A CN 102784318A
- Authority
- CN
- China
- Prior art keywords
- grams
- insomnia
- chinese medicine
- traditional chinese
- herba
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 208000013738 Sleep Initiation and Maintenance disease Diseases 0.000 title claims abstract description 26
- 206010022437 insomnia Diseases 0.000 title claims abstract description 26
- 239000003814 drug Substances 0.000 title claims abstract description 24
- 230000027939 micturition Effects 0.000 title claims abstract description 23
- 238000002360 preparation method Methods 0.000 title claims abstract description 9
- 238000011282 treatment Methods 0.000 claims abstract description 19
- 235000009797 Lagenaria vulgaris Nutrition 0.000 claims abstract description 7
- 241001619461 Poria <basidiomycete fungus> Species 0.000 claims abstract description 7
- 239000007788 liquid Substances 0.000 claims abstract description 7
- 239000010453 quartz Substances 0.000 claims abstract description 7
- VYPSYNLAJGMNEJ-UHFFFAOYSA-N silicon dioxide Inorganic materials O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 claims abstract description 7
- 210000000582 semen Anatomy 0.000 claims description 18
- 229940079593 drug Drugs 0.000 claims description 11
- 210000002700 urine Anatomy 0.000 claims description 10
- 241001450685 Corallium japonicum Species 0.000 claims description 6
- 235000005983 Crescentia cujete Nutrition 0.000 claims description 6
- 241000628997 Flos Species 0.000 claims description 6
- 241001243091 Gryllotalpa Species 0.000 claims description 6
- 241000382923 Oxya chinensis Species 0.000 claims description 6
- 239000000796 flavoring agent Substances 0.000 claims description 6
- 235000019634 flavors Nutrition 0.000 claims description 6
- 240000009087 Crescentia cujete Species 0.000 claims description 5
- 239000003643 water by type Substances 0.000 claims description 3
- 230000000694 effects Effects 0.000 abstract description 9
- 231100000331 toxic Toxicity 0.000 abstract description 3
- 230000002588 toxic effect Effects 0.000 abstract description 3
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 abstract description 3
- 239000000935 antidepressant agent Substances 0.000 abstract description 2
- 229940005513 antidepressants Drugs 0.000 abstract description 2
- 239000002249 anxiolytic agent Substances 0.000 abstract description 2
- 230000008901 benefit Effects 0.000 abstract description 2
- 230000004799 sedative–hypnotic effect Effects 0.000 abstract description 2
- 241001485474 Adonis amurensis Species 0.000 abstract 1
- 206010067484 Adverse reaction Diseases 0.000 abstract 1
- 241000722953 Akebia Species 0.000 abstract 1
- 240000007185 Albizia julibrissin Species 0.000 abstract 1
- 235000011468 Albizia julibrissin Nutrition 0.000 abstract 1
- 244000080767 Areca catechu Species 0.000 abstract 1
- 244000036905 Benincasa cerifera Species 0.000 abstract 1
- 235000011274 Benincasa cerifera Nutrition 0.000 abstract 1
- 244000132059 Carica parviflora Species 0.000 abstract 1
- 235000014653 Carica parviflora Nutrition 0.000 abstract 1
- 241000233839 Commelina communis Species 0.000 abstract 1
- 244000183914 Dianthus superbus Species 0.000 abstract 1
- 235000013535 Dianthus superbus Nutrition 0.000 abstract 1
- 240000004670 Glycyrrhiza echinata Species 0.000 abstract 1
- 235000001453 Glycyrrhiza echinata Nutrition 0.000 abstract 1
- 235000006200 Glycyrrhiza glabra Nutrition 0.000 abstract 1
- 235000017382 Glycyrrhiza lepidota Nutrition 0.000 abstract 1
- 241001243087 Gryllotalpidae Species 0.000 abstract 1
- 244000303847 Lagenaria vulgaris Species 0.000 abstract 1
- 244000187664 Nerium oleander Species 0.000 abstract 1
- 241000238814 Orthoptera Species 0.000 abstract 1
- 241000208977 Polygalaceae Species 0.000 abstract 1
- 244000292697 Polygonum aviculare Species 0.000 abstract 1
- 235000006386 Polygonum aviculare Nutrition 0.000 abstract 1
- 240000001341 Reynoutria japonica Species 0.000 abstract 1
- 235000018167 Reynoutria japonica Nutrition 0.000 abstract 1
- 244000290970 Tetrapanax papyrifer Species 0.000 abstract 1
- 240000001417 Vigna umbellata Species 0.000 abstract 1
- 235000011453 Vigna umbellata Nutrition 0.000 abstract 1
- 244000089698 Zanthoxylum simulans Species 0.000 abstract 1
- 240000008042 Zea mays Species 0.000 abstract 1
- 235000005824 Zea mays ssp. parviglumis Nutrition 0.000 abstract 1
- 235000002017 Zea mays subsp mays Nutrition 0.000 abstract 1
- 230000006838 adverse reaction Effects 0.000 abstract 1
- 230000000949 anxiolytic effect Effects 0.000 abstract 1
- 229940005530 anxiolytics Drugs 0.000 abstract 1
- 210000000988 bone and bone Anatomy 0.000 abstract 1
- WUKWITHWXAAZEY-UHFFFAOYSA-L calcium difluoride Chemical compound [F-].[F-].[Ca+2] WUKWITHWXAAZEY-UHFFFAOYSA-L 0.000 abstract 1
- 235000005822 corn Nutrition 0.000 abstract 1
- 239000010436 fluorite Substances 0.000 abstract 1
- 235000008216 herbs Nutrition 0.000 abstract 1
- 229940010454 licorice Drugs 0.000 abstract 1
- 229940126673 western medicines Drugs 0.000 abstract 1
- 210000002216 heart Anatomy 0.000 description 28
- 208000004880 Polyuria Diseases 0.000 description 20
- 230000035619 diuresis Effects 0.000 description 20
- 235000009508 confectionery Nutrition 0.000 description 19
- 206010030113 Oedema Diseases 0.000 description 16
- 210000003734 kidney Anatomy 0.000 description 16
- 230000001939 inductive effect Effects 0.000 description 15
- 210000004072 lung Anatomy 0.000 description 14
- 210000000952 spleen Anatomy 0.000 description 12
- 210000004185 liver Anatomy 0.000 description 11
- 231100000614 poison Toxicity 0.000 description 9
- 230000001737 promoting effect Effects 0.000 description 9
- 230000002936 tranquilizing effect Effects 0.000 description 9
- 210000003932 urinary bladder Anatomy 0.000 description 8
- 230000007812 deficiency Effects 0.000 description 7
- 238000010792 warming Methods 0.000 description 7
- 208000002193 Pain Diseases 0.000 description 6
- 239000008280 blood Substances 0.000 description 6
- 210000004369 blood Anatomy 0.000 description 6
- 210000002784 stomach Anatomy 0.000 description 6
- 208000011580 syndromic disease Diseases 0.000 description 6
- 230000002411 adverse Effects 0.000 description 5
- 208000002173 dizziness Diseases 0.000 description 5
- 230000000968 intestinal effect Effects 0.000 description 5
- 210000000813 small intestine Anatomy 0.000 description 5
- 238000002560 therapeutic procedure Methods 0.000 description 5
- 239000003440 toxic substance Substances 0.000 description 5
- 206010010774 Constipation Diseases 0.000 description 4
- 206010010904 Convulsion Diseases 0.000 description 4
- 206010012335 Dependence Diseases 0.000 description 4
- 206010062717 Increased upper airway secretion Diseases 0.000 description 4
- 206010041349 Somnolence Diseases 0.000 description 4
- 230000036461 convulsion Effects 0.000 description 4
- 210000002429 large intestine Anatomy 0.000 description 4
- 210000005036 nerve Anatomy 0.000 description 4
- 208000026435 phlegm Diseases 0.000 description 4
- 230000007096 poisonous effect Effects 0.000 description 4
- 206010007247 Carbuncle Diseases 0.000 description 3
- 206010012735 Diarrhoea Diseases 0.000 description 3
- 241000201295 Euphrasia Species 0.000 description 3
- 206010019233 Headaches Diseases 0.000 description 3
- 241000475481 Nebula Species 0.000 description 3
- 206010033557 Palpitations Diseases 0.000 description 3
- 230000003213 activating effect Effects 0.000 description 3
- 230000000954 anitussive effect Effects 0.000 description 3
- 229940124584 antitussives Drugs 0.000 description 3
- 239000003212 astringent agent Substances 0.000 description 3
- 230000000740 bleeding effect Effects 0.000 description 3
- 230000017531 blood circulation Effects 0.000 description 3
- PCHPORCSPXIHLZ-UHFFFAOYSA-N diphenhydramine hydrochloride Chemical compound [Cl-].C=1C=CC=CC=1C(OCC[NH+](C)C)C1=CC=CC=C1 PCHPORCSPXIHLZ-UHFFFAOYSA-N 0.000 description 3
- 231100000869 headache Toxicity 0.000 description 3
- 238000000034 method Methods 0.000 description 3
- 231100000862 numbness Toxicity 0.000 description 3
- 231100000572 poisoning Toxicity 0.000 description 3
- 230000000607 poisoning effect Effects 0.000 description 3
- 238000010926 purge Methods 0.000 description 3
- 238000011084 recovery Methods 0.000 description 3
- 230000001105 regulatory effect Effects 0.000 description 3
- 208000024891 symptom Diseases 0.000 description 3
- 230000001225 therapeutic effect Effects 0.000 description 3
- CPELXLSAUQHCOX-UHFFFAOYSA-M Bromide Chemical compound [Br-] CPELXLSAUQHCOX-UHFFFAOYSA-M 0.000 description 2
- 208000010412 Glaucoma Diseases 0.000 description 2
- 206010020751 Hypersensitivity Diseases 0.000 description 2
- 208000001431 Psychomotor Agitation Diseases 0.000 description 2
- 206010038743 Restlessness Diseases 0.000 description 2
- 206010040943 Skin Ulcer Diseases 0.000 description 2
- 208000005392 Spasm Diseases 0.000 description 2
- 208000026935 allergic disease Diseases 0.000 description 2
- 230000007815 allergy Effects 0.000 description 2
- 230000009286 beneficial effect Effects 0.000 description 2
- 210000000941 bile Anatomy 0.000 description 2
- 230000036772 blood pressure Effects 0.000 description 2
- 230000002496 gastric effect Effects 0.000 description 2
- 230000005764 inhibitory process Effects 0.000 description 2
- 230000001717 pathogenic effect Effects 0.000 description 2
- 230000008569 process Effects 0.000 description 2
- 230000009467 reduction Effects 0.000 description 2
- 230000003014 reinforcing effect Effects 0.000 description 2
- 230000003248 secreting effect Effects 0.000 description 2
- 231100000019 skin ulcer Toxicity 0.000 description 2
- 230000000638 stimulation Effects 0.000 description 2
- 231100000419 toxicity Toxicity 0.000 description 2
- 230000001988 toxicity Effects 0.000 description 2
- 230000001457 vasomotor Effects 0.000 description 2
- 210000003462 vein Anatomy 0.000 description 2
- 239000011800 void material Substances 0.000 description 2
- XQJMXPAEFMWDOZ-UHFFFAOYSA-N 3exo-benzoyloxy-tropane Natural products CN1C(C2)CCC1CC2OC(=O)C1=CC=CC=C1 XQJMXPAEFMWDOZ-UHFFFAOYSA-N 0.000 description 1
- 206010000060 Abdominal distension Diseases 0.000 description 1
- 206010063409 Acarodermatitis Diseases 0.000 description 1
- 208000002874 Acne Vulgaris Diseases 0.000 description 1
- 208000007848 Alcoholism Diseases 0.000 description 1
- WKBOTKDWSSQWDR-UHFFFAOYSA-N Bromine atom Chemical compound [Br] WKBOTKDWSSQWDR-UHFFFAOYSA-N 0.000 description 1
- JZUFKLXOESDKRF-UHFFFAOYSA-N Chlorothiazide Chemical compound C1=C(Cl)C(S(=O)(=O)N)=CC2=C1NCNS2(=O)=O JZUFKLXOESDKRF-UHFFFAOYSA-N 0.000 description 1
- 241000721047 Danaus plexippus Species 0.000 description 1
- 206010052804 Drug tolerance Diseases 0.000 description 1
- 208000008967 Enuresis Diseases 0.000 description 1
- 208000007882 Gastritis Diseases 0.000 description 1
- JMBQKKAJIKAWKF-UHFFFAOYSA-N Glutethimide Chemical compound C=1C=CC=CC=1C1(CC)CCC(=O)NC1=O JMBQKKAJIKAWKF-UHFFFAOYSA-N 0.000 description 1
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical class OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 description 1
- 206010020772 Hypertension Diseases 0.000 description 1
- 206010061218 Inflammation Diseases 0.000 description 1
- 206010023126 Jaundice Diseases 0.000 description 1
- JEYCTXHKTXCGPB-UHFFFAOYSA-N Methaqualone Chemical compound CC1=CC=CC=C1N1C(=O)C2=CC=CC=C2N=C1C JEYCTXHKTXCGPB-UHFFFAOYSA-N 0.000 description 1
- SIDLZWOQUZRBRU-UHFFFAOYSA-N Methyprylon Chemical compound CCC1(CC)C(=O)NCC(C)C1=O SIDLZWOQUZRBRU-UHFFFAOYSA-N 0.000 description 1
- 244000174681 Michelia champaca Species 0.000 description 1
- QQXLDOJGLXJCSE-UHFFFAOYSA-N N-methylnortropinone Natural products C1C(=O)CC2CCC1N2C QQXLDOJGLXJCSE-UHFFFAOYSA-N 0.000 description 1
- 206010028813 Nausea Diseases 0.000 description 1
- 208000003251 Pruritus Diseases 0.000 description 1
- QIZDQFOVGFDBKW-DHBOJHSNSA-N Pseudotropine Natural products OC1C[C@@H]2[N+](C)[C@H](C1)CC2 QIZDQFOVGFDBKW-DHBOJHSNSA-N 0.000 description 1
- 241000447727 Scabies Species 0.000 description 1
- 208000007107 Stomach Ulcer Diseases 0.000 description 1
- 208000007271 Substance Withdrawal Syndrome Diseases 0.000 description 1
- 208000025865 Ulcer Diseases 0.000 description 1
- 206010047700 Vomiting Diseases 0.000 description 1
- 206010000496 acne Diseases 0.000 description 1
- 239000002671 adjuvant Substances 0.000 description 1
- 230000000172 allergic effect Effects 0.000 description 1
- 229940125713 antianxiety drug Drugs 0.000 description 1
- 208000006673 asthma Diseases 0.000 description 1
- 208000010668 atopic eczema Diseases 0.000 description 1
- 229940125717 barbiturate Drugs 0.000 description 1
- 229940006460 bromide ion Drugs 0.000 description 1
- GDTBXPJZTBHREO-UHFFFAOYSA-N bromine Substances BrBr GDTBXPJZTBHREO-UHFFFAOYSA-N 0.000 description 1
- 229910052794 bromium Inorganic materials 0.000 description 1
- 230000009172 bursting Effects 0.000 description 1
- 239000003795 chemical substances by application Substances 0.000 description 1
- RNFNDJAIBTYOQL-UHFFFAOYSA-N chloral hydrate Chemical compound OC(O)C(Cl)(Cl)Cl RNFNDJAIBTYOQL-UHFFFAOYSA-N 0.000 description 1
- 229960002327 chloral hydrate Drugs 0.000 description 1
- 239000000812 cholinergic antagonist Substances 0.000 description 1
- 230000008602 contraction Effects 0.000 description 1
- 230000018109 developmental process Effects 0.000 description 1
- AAOVKJBEBIDNHE-UHFFFAOYSA-N diazepam Chemical compound N=1CC(=O)N(C)C2=CC=C(Cl)C=C2C=1C1=CC=CC=C1 AAOVKJBEBIDNHE-UHFFFAOYSA-N 0.000 description 1
- 229960003529 diazepam Drugs 0.000 description 1
- 201000010099 disease Diseases 0.000 description 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 1
- 230000009429 distress Effects 0.000 description 1
- 238000005516 engineering process Methods 0.000 description 1
- 206010015037 epilepsy Diseases 0.000 description 1
- GXRZIMHKGDIBEW-UHFFFAOYSA-N ethinamate Chemical compound NC(=O)OC1(C#C)CCCCC1 GXRZIMHKGDIBEW-UHFFFAOYSA-N 0.000 description 1
- 229960002209 ethinamate Drugs 0.000 description 1
- 230000029142 excretion Effects 0.000 description 1
- 239000012530 fluid Substances 0.000 description 1
- 235000013305 food Nutrition 0.000 description 1
- 201000005917 gastric ulcer Diseases 0.000 description 1
- 210000001035 gastrointestinal tract Anatomy 0.000 description 1
- 229960002972 glutethimide Drugs 0.000 description 1
- 230000026781 habituation Effects 0.000 description 1
- 230000035876 healing Effects 0.000 description 1
- 230000023597 hemostasis Effects 0.000 description 1
- 208000021760 high fever Diseases 0.000 description 1
- 229960002003 hydrochlorothiazide Drugs 0.000 description 1
- 230000000147 hypnotic effect Effects 0.000 description 1
- 201000001881 impotence Diseases 0.000 description 1
- 230000004054 inflammatory process Effects 0.000 description 1
- 238000010255 intramuscular injection Methods 0.000 description 1
- 239000007927 intramuscular injection Substances 0.000 description 1
- 238000010253 intravenous injection Methods 0.000 description 1
- 230000007803 itching Effects 0.000 description 1
- 230000003907 kidney function Effects 0.000 description 1
- 230000003908 liver function Effects 0.000 description 1
- 230000007774 longterm Effects 0.000 description 1
- 201000007227 lymph node tuberculosis Diseases 0.000 description 1
- 206010025482 malaise Diseases 0.000 description 1
- 230000002175 menstrual effect Effects 0.000 description 1
- 229960002803 methaqualone Drugs 0.000 description 1
- 229960000316 methyprylon Drugs 0.000 description 1
- 239000008267 milk Substances 0.000 description 1
- 210000004080 milk Anatomy 0.000 description 1
- 235000013336 milk Nutrition 0.000 description 1
- 206010028417 myasthenia gravis Diseases 0.000 description 1
- 230000002107 myocardial effect Effects 0.000 description 1
- 230000008693 nausea Effects 0.000 description 1
- 244000045947 parasite Species 0.000 description 1
- 244000052769 pathogen Species 0.000 description 1
- 230000008506 pathogenesis Effects 0.000 description 1
- DDBREPKUVSBGFI-UHFFFAOYSA-N phenobarbital Chemical compound C=1C=CC=CC=1C1(CC)C(=O)NC(=O)NC1=O DDBREPKUVSBGFI-UHFFFAOYSA-N 0.000 description 1
- 229960002695 phenobarbital Drugs 0.000 description 1
- 208000037920 primary disease Diseases 0.000 description 1
- 210000001034 respiratory center Anatomy 0.000 description 1
- 230000029058 respiratory gaseous exchange Effects 0.000 description 1
- 235000002020 sage Nutrition 0.000 description 1
- 235000015598 salt intake Nutrition 0.000 description 1
- 150000003839 salts Chemical class 0.000 description 1
- 208000005687 scabies Diseases 0.000 description 1
- 230000028327 secretion Effects 0.000 description 1
- 210000002460 smooth muscle Anatomy 0.000 description 1
- 230000002048 spasmolytic effect Effects 0.000 description 1
- 230000002269 spontaneous effect Effects 0.000 description 1
- 230000004936 stimulating effect Effects 0.000 description 1
- 238000005728 strengthening Methods 0.000 description 1
- 230000035900 sweating Effects 0.000 description 1
- 210000002435 tendon Anatomy 0.000 description 1
- 206010043554 thrombocytopenia Diseases 0.000 description 1
- 201000005060 thrombophlebitis Diseases 0.000 description 1
- 230000017423 tissue regeneration Effects 0.000 description 1
- CYHOMWAPJJPNMW-JIGDXULJSA-N tropine Chemical compound C1[C@@H](O)C[C@H]2CC[C@@H]1N2C CYHOMWAPJJPNMW-JIGDXULJSA-N 0.000 description 1
- 231100000397 ulcer Toxicity 0.000 description 1
- 230000002485 urinary effect Effects 0.000 description 1
- 238000009423 ventilation Methods 0.000 description 1
- 230000008673 vomiting Effects 0.000 description 1
Landscapes
- Medicines Containing Plant Substances (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Abstract
Description
年龄(岁) | 23~30 | 31~40 | 41~50 | 51~60 |
例数 | 17 | 212 | 156 | 3 |
百分比 | 4.4% | 54.6% | 40.2% | 0.8% |
疗效 | 治愈 | 好转 | 无效 |
例数 | 385 | 3 | 无 |
百分比 | 99.2% | 0.8% | 无 |
治疗天数 | 3~6 | 7~10 | 11~15 | 16~22 |
例数 | 12 | 237 | 131 | 8 |
百分比 | 3.1% | 61.1% | 33.8% | 2% |
Claims (1)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201210270915.5A CN102784318B (zh) | 2012-08-01 | 2012-08-01 | 一种治疗尿频尿急型失眠的中药制备方法 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201210270915.5A CN102784318B (zh) | 2012-08-01 | 2012-08-01 | 一种治疗尿频尿急型失眠的中药制备方法 |
Publications (2)
Publication Number | Publication Date |
---|---|
CN102784318A true CN102784318A (zh) | 2012-11-21 |
CN102784318B CN102784318B (zh) | 2014-01-29 |
Family
ID=47150035
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201210270915.5A Expired - Fee Related CN102784318B (zh) | 2012-08-01 | 2012-08-01 | 一种治疗尿频尿急型失眠的中药制备方法 |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN102784318B (zh) |
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN106110154A (zh) * | 2016-07-19 | 2016-11-16 | 周继英 | 一种治疗小便淋沥的中药组合物 |
Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN1753682A (zh) * | 2003-01-16 | 2006-03-29 | 利盛私人有限公司 | 用于前列腺疾病的草药组合物 |
CN1806840A (zh) * | 2005-01-21 | 2006-07-26 | 中国科学院上海药物研究所 | 一种中药复方制剂及其制备方法 |
-
2012
- 2012-08-01 CN CN201210270915.5A patent/CN102784318B/zh not_active Expired - Fee Related
Patent Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN1753682A (zh) * | 2003-01-16 | 2006-03-29 | 利盛私人有限公司 | 用于前列腺疾病的草药组合物 |
CN1806840A (zh) * | 2005-01-21 | 2006-07-26 | 中国科学院上海药物研究所 | 一种中药复方制剂及其制备方法 |
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN106110154A (zh) * | 2016-07-19 | 2016-11-16 | 周继英 | 一种治疗小便淋沥的中药组合物 |
Also Published As
Publication number | Publication date |
---|---|
CN102784318B (zh) | 2014-01-29 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN102813792B (zh) | 一种治疗痰火扰心型失眠的中药制备方法 | |
CN102784319A (zh) | 一种治疗气阴两虚型失眠的中药制备方法 | |
CN102813831B (zh) | 一种治疗阴虚火旺型失眠的中药制备方法 | |
CN102784358B (zh) | 一种治疗肝郁型失眠的中药制备方法 | |
CN102784273B (zh) | 一种治疗高血压型失眠的中药制备方法 | |
CN102805849A (zh) | 一种治疗心胆虚怯型失眠的中药制备方法 | |
CN102813821B (zh) | 一种治疗胃热型失眠的中药制备方法 | |
CN102813797A (zh) | 一种治疗酗酒型失眠的中药制备方法 | |
CN102793863A (zh) | 一种治疗眼底充血型失眠的中药制备方法 | |
CN102784279B (zh) | 一种治疗便秘型失眠的中药制备方法 | |
CN102784318B (zh) | 一种治疗尿频尿急型失眠的中药制备方法 | |
CN102793865B (zh) | 一种治疗胃中不和型失眠的中药制备方法 | |
CN102784302A (zh) | 一种治疗肾阴亏虚型失眠的中药制备方法 | |
CN102784356B (zh) | 一种治疗疼痛型失眠的中药制备方法 | |
CN102805812B (zh) | 一种治疗嗜食大蒜型失眠的中药制备方法 | |
CN102784357B (zh) | 一种治疗嗜饮浓茶型失眠的中药制备方法 | |
CN102813879B (zh) | 一种治疗瘀血型不寐的中药制备方法 | |
CN102805813B (zh) | 一种治疗嗜食辣椒型失眠的中药制备方法 | |
CN102784326B (zh) | 一种治疗溲赤型失眠的中药制备方法 | |
CN102784250A (zh) | 一种治疗暴饮暴食型失眠的中药制备方法 | |
CN102805801B (zh) | 一种治疗吸烟型失眠的中药制备方法 | |
CN102784278B (zh) | 一种治疗虫积型失眠的中药制备方法 | |
CN102805784B (zh) | 一种治疗搔痒型失眠的中药制备方法 | |
CN102784349B (zh) | 一种治疗过食油腻型失眠的中药制备方法 | |
CN102784298B (zh) | 一种治疗嗜食芥末型失眠的中药制备方法 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
C10 | Entry into substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
ASS | Succession or assignment of patent right |
Owner name: CHEN FANG Free format text: FORMER OWNER: MA NIANFANG Effective date: 20131224 |
|
C41 | Transfer of patent application or patent right or utility model | ||
C53 | Correction of patent of invention or patent application | ||
CB03 | Change of inventor or designer information |
Inventor after: Chen Fang Inventor after: Zhou Xiaosheng Inventor after: Ma Xueying Inventor after: Wang Bin Inventor after: Sun Dakang Inventor after: Zhang Qingqing Inventor before: Ma Nianfang |
|
COR | Change of bibliographic data |
Free format text: CORRECT: ADDRESS; FROM: 250013 JINAN, SHANDONG PROVINCE TO: 256603 BINZHOU, SHANDONG PROVINCE Free format text: CORRECT: INVENTOR; FROM: MA NIANFANG TO: CHEN FANG ZHOU XIAOSHENG MA XUEYING WANG BIN SUN DAKANG ZHANG QINGQING |
|
TA01 | Transfer of patent application right |
Effective date of registration: 20131224 Address after: 256603, the Yellow River Road, Shandong, No. 661, Affiliated Hospital of Binzhou Medical College, two Applicant after: Chen Fang Address before: 46 Shandong Chest Hospital, Lixia mountain road, Lixia District, Shandong, Ji'nan 250013, China Applicant before: Ma Nianfang |
|
C14 | Grant of patent or utility model | ||
GR01 | Patent grant | ||
CF01 | Termination of patent right due to non-payment of annual fee |
Granted publication date: 20140129 Termination date: 20140801 |
|
EXPY | Termination of patent right or utility model |